240
Participants
Start Date
October 9, 2023
Primary Completion Date
May 1, 2025
Study Completion Date
November 1, 2025
Cardiovascular magnetic resonance scan - 3T scanner (Siemens Vida)
4 study groups will undergo testing with 12-lead ECG, blood test, cardiac MRI, cardiopulmonary exercise testing and 24 hour holter monitor. A subgroup (N=50 anticipated) will undergo genetic testing.
RECRUITING
Royal Brompton Hospital, London
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Cardiac Risk in the Young
OTHER
St George's, University of London
OTHER
Imperial College London
OTHER